Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The QuickStart study aims to assess the impact of three models of HCV care on HCV treatment
uptake and cure among people who inject drugs. Rapid point-of-care (POC) HCV testing and
test-and-treat strategies will be utilised in primary health care settings across Australia.
Phase:
Phase 4
Details
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Treatments:
Antibodies Hepatitis C Antibodies Sofosbuvir Velpatasvir